iASPP Antibodies

Santa Cruz Biotechnology provides a broad selection of iASPP Antibodies for various research applications. iASPP Antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). iASPP, or inhibitor of apoptosis-stimulating protein of p53, plays a critical role in regulating apoptosis and cell survival, particularly in cancer development and progression. By modulating p53 activity, iASPP influences cellular responses to stress and contributes to tumorigenesis. Understanding iASPP function is essential for developing targeted cancer treatments. Researchers can investigate the molecular mechanisms of apoptosis and cell survival pathways using specific monoclonal antibodies. Advanced research techniques enable detailed analysis of iASPP expression patterns and interactions with other proteins. Studying iASPP's role in different cancer types may reveal new therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing cancer biology understanding and developing innovative treatment approaches.